Mechanisms activated by kidney disease and the loss of muscle mass.

The daily turnover of cellular proteins is large, with amounts equivalent to the protein contained in 1.0 to 1.5 kg of muscle. Consequently, even a small, persistent increase in the rate of protein degradation or decrease in protein synthesis will result in substantial loss of muscle mass. Activation of protein degradation in the ubiquitin-proteasome system is the mechanism contributing to loss of muscle mass in kidney disease. Because other catabolic conditions also stimulate this system to cause loss of muscle mass, the identification of activating signals is of interest. A complication of kidney disease, metabolic acidosis, activates this system in muscle by a process that requires glucocorticoids. The influence of inflammatory cytokines on this system in muscle is more complicated, as evidence indicates that cytokines suppress the system, but glucocorticoids block the effect of cytokines to slow protein breakdown in the system. New information identifying mechanisms that activate protein breakdown and the rebuilding of muscle fibers would lead to therapies that successfully prevent the loss of muscle mass in kidney disease and other catabolic illnesses.

[1]  W. Mitch,et al.  ENaC Degradation in A6 Cells by the Ubiquitin-Proteosome Proteolytic Pathway* , 2001, The Journal of Biological Chemistry.

[2]  W. Mitch,et al.  Transcription factors and muscle cachexia: is there a therapeutic target? , 2001, The Lancet.

[3]  C. Y. Wang,et al.  NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. , 2000, Science.

[4]  W. Mitch,et al.  Glucocorticoids Induce Proteasome C3 Subunit Expression in L6 Muscle Cells by Opposing the Suppression of Its Transcription by NF-κB* , 2000, The Journal of Biological Chemistry.

[5]  T. Ikizler What Are the Causes and Consequences of the Chronic Inflammatory State in Chronic Dialysis Patients? , 2000, Seminars in dialysis.

[6]  Hans-Georg Rammensee,et al.  Perfect use of imperfection , 2000, Nature.

[7]  A. Goldberg,et al.  Ubiquitin conjugation by the N-end rule pathway and mRNAs for its components increase in muscles of diabetic rats. , 1999, The Journal of clinical investigation.

[8]  A. Atfi,et al.  Insulin Antiapoptotic Signaling Involves Insulin Activation of the Nuclear Factor κB-dependent Survival Genes Encoding Tumor Necrosis Factor Receptor-associated Factor 2 and Manganese-superoxide Dismutase* , 1999, The Journal of Biological Chemistry.

[9]  M. Palacín,et al.  Insulin-like Growth Factor-II, Phosphatidylinositol 3-Kinase, Nuclear Factor-κB and Inducible Nitric-oxide Synthase Define a Common Myogenic Signaling Pathway* , 1999, The Journal of Biological Chemistry.

[10]  Claudine Jurkovitz,et al.  Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscle wasting. , 1999, American journal of physiology. Cell physiology.

[11]  J. Beckmann,et al.  Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IκBα/NF-κB pathway in limb-girdle muscular dystrophy type 2A , 1999, Nature Medicine.

[12]  A. Goldberg,et al.  Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. , 1999, The Journal of nutrition.

[13]  G. Kaysen Biological basis of hypoalbuminemia in ESRD. , 1998, Journal of the American Society of Nephrology : JASN.

[14]  A. Goldberg,et al.  Rates of ubiquitin conjugation increase when muscles atrophy, largely through activation of the N-end rule pathway. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[15]  A. Goldberg,et al.  The N-end Rule Pathway Catalyzes a Major Fraction of the Protein Degradation in Skeletal Muscle* , 1998, The Journal of Biological Chemistry.

[16]  F. Scolari,et al.  Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[17]  K. Davies,et al.  Peroxynitrite Increases the Degradation of Aconitase and Other Cellular Proteins by Proteasome* , 1998, The Journal of Biological Chemistry.

[18]  B. Lindholm,et al.  Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. , 1998, Kidney international.

[19]  J. Hasbargen,et al.  Correction of metabolic acidosis and its effect on albumin in chronic hemodialysis patients. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  J. Walls,et al.  Role of an improvement in acid-base status and nutrition in CAPD patients. , 1997, Kidney international.

[21]  A. Manatunga,et al.  Mechanisms permitting nephrotic patients to achieve nitrogen equilibrium with a protein-restricted diet. , 1997, The Journal of clinical investigation.

[22]  S. Downie,et al.  Correction of acidosis in hemodialysis decreases whole-body protein degradation. , 1997, Journal of the American Society of Nephrology : JASN.

[23]  T. Meyer,et al.  Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle. , 1997, The Journal of clinical investigation.

[24]  A. Goldberg,et al.  Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. , 1996, The New England journal of medicine.

[25]  A. Varshavsky,et al.  The N-end rule: functions, mysteries, uses. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[26]  A. Goldberg,et al.  Importance of the ATP-Ubiquitin-Proteasome Pathway in the Degradation of Soluble and Myofibrillar Proteins in Rabbit Muscle Extracts* , 1996, The Journal of Biological Chemistry.

[27]  L. Phillips,et al.  Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome proteolytic pathway by a mechanism including gene transcription. , 1996, The Journal of clinical investigation.

[28]  T. Reinheckel,et al.  Degradation of Oxidized Proteins in K562 Human Hematopoietic Cells by Proteasome* , 1996, The Journal of Biological Chemistry.

[29]  S. Downie,et al.  Correction of acidosis in CAPD decreases whole body protein degradation. , 1996, Kidney international.

[30]  B. Beaufrère,et al.  Increased mRNA levels for components of the lysosomal, Ca2+-activated, and ATP-ubiquitin-dependent proteolytic pathways in skeletal muscle from head trauma patients. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[31]  W. Mitch,et al.  The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway. , 1996, The Journal of clinical investigation.

[32]  W. Mitch,et al.  Protein degradation and increased mRNAs encoding proteins of the ubiquitin-proteasome proteolytic pathway in BC3H1 myocytes require an interaction between glucocorticoids and acidification. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Riordan,et al.  Multiple proteolytic systems, including the proteasome, contribute to CFTR processing , 1995, Cell.

[34]  W. Mitch,et al.  Rat muscle branched-chain ketoacid dehydrogenase activity and mRNAs increase with extracellular acidemia. , 1995, The American journal of physiology.

[35]  V. Young,et al.  Long-term adaptive responses to dietary protein restriction in chronic renal failure. , 1995, The American journal of physiology.

[36]  T. Reinheckel,et al.  Proteolysis in Cultured Liver Epithelial Cells during Oxidative Stress , 1995, The Journal of Biological Chemistry.

[37]  M. McNurlan,et al.  Chronic metabolic acidosis decreases albumin synthesis and induces negative nitrogen balance in humans. , 1995, The Journal of clinical investigation.

[38]  W. Mitch,et al.  Acidosis and glucocorticoids concomitantly increase ubiquitin and proteasome subunit mRNAs in rat muscle. , 1994, The American journal of physiology.

[39]  Tom Maniatis,et al.  The ubiquitinproteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB , 1994, Cell.

[40]  A. Goldberg,et al.  Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules , 1994, Cell.

[41]  G. Deferrari,et al.  Skeletal muscle protein synthesis and degradation in patients with chronic renal failure. , 1994, Kidney international.

[42]  A. Goldberg,et al.  Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes. , 1994, The Journal of clinical investigation.

[43]  V. Young,et al.  Adaptive responses to very low protein diets: the first comparison of ketoacids to essential amino acids. , 1994, Kidney international.

[44]  B. Pereira,et al.  Plasma levels of IL-1β, TNFα and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients , 1994 .

[45]  M. Namiki,et al.  Interleukin-8 in chronic renal failure and dialysis patients. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[46]  C. Scrimgeour,et al.  Correction of acidosis in humans with CRF decreases protein degradation and amino acid oxidation. , 1993, The American journal of physiology.

[47]  A. Goldberg,et al.  Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting. , 1993, The American journal of physiology.

[48]  C. Scrimgeour,et al.  Ammonium chloride-induced acidosis increases protein breakdown and amino acid oxidation in humans. , 1992, The American journal of physiology.

[49]  J. Bailey,et al.  Chronic metabolic acidosis accelerates whole body proteolysis and oxidation in awake rats. , 1992, Kidney international.

[50]  C. Dinarello Cytokines: agents provocateurs in hemodialysis? , 1992, Kidney international.

[51]  J. Walls,et al.  Metabolic acidosis and skeletal muscle adaptation to low protein diets in chronic uremia. , 1991, Kidney international.

[52]  B. Descamps-Latscha,et al.  Elevated circulating levels of interleukin-6 in patients with chronic renal failure. , 1991, Kidney international.

[53]  R. Hoerr,et al.  Adaptation to low-protein diets in renal failure: leucine turnover and nitrogen balance. , 1990, Journal of the American Society of Nephrology : JASN.

[54]  B. Descamps-Latscha,et al.  Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha. , 1990, Kidney international.

[55]  W. Mitch,et al.  Branched-chain amino acid metabolism in rat muscle: abnormal regulation in acidosis. , 1987, The American journal of physiology.

[56]  W. Mitch,et al.  Mechanisms for defects in muscle protein metabolism in rats with chronic uremia. Influence of metabolic acidosis. , 1987, The Journal of clinical investigation.

[57]  A. Haas,et al.  The dynamics of ubiquitin pools within cultured human lung fibroblasts. , 1987, The Journal of biological chemistry.

[58]  W. Mitch,et al.  Metabolic acidosis stimulates protein degradation in rat muscle by a glucocorticoid-dependent mechanism. , 1986, The Journal of clinical investigation.

[59]  M. Mcgeown,et al.  The effect of the correction of metabolic acidosis on nitrogen and potassium balance of patients with chronic renal failure. , 1984, The American journal of clinical nutrition.